Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Levy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacology|June 9, 2015
FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testingKenneth D Levy, Victoria M Pratt, Todd C Skaar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical PracticeMarc B Rosenman, Brian Decker, Kenneth D Levy, et al.
Frontiers in Genetics|July 17, 2020
Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical TrialEbony Shah-Williams, Kenneth D Levy, Yong Zang, et al.
SAGE Open Medicine|February 3, 2016
Pharmacogenomically actionable medications in a safety net health care systemJanet S Carpenter, Marc B Rosenman, Mitchell R Knisely, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cisVictoria M Pratt, Brittany N Beyer, Daniel L Koller, et al.
Journal of Personalized Medicine|July 26, 2018
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network SurveyAniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, et al.
Molecular Genetics & Genomic Medicine|March 22, 2019
IGNITE network: Response of patients to genomic medicine interventionsLori A Orlando, Corrine Voils, Carol R Horowitz, et al.
Pharmacogenomics|February 21, 2019
Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trialCathy R Fulton, Yong Zang, Zeruesenay Desta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 31, 2018
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 13, 2018
Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|June 9, 2015
FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testingKenneth D Levy, Victoria M Pratt, Todd C Skaar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical PracticeMarc B Rosenman, Brian Decker, Kenneth D Levy, et al.
Frontiers in Genetics|July 17, 2020
Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical TrialEbony Shah-Williams, Kenneth D Levy, Yong Zang, et al.
SAGE Open Medicine|February 3, 2016
Pharmacogenomically actionable medications in a safety net health care systemJanet S Carpenter, Marc B Rosenman, Mitchell R Knisely, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cisVictoria M Pratt, Brittany N Beyer, Daniel L Koller, et al.
Journal of Personalized Medicine|July 26, 2018
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network SurveyAniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, et al.
Molecular Genetics & Genomic Medicine|March 22, 2019
IGNITE network: Response of patients to genomic medicine interventionsLori A Orlando, Corrine Voils, Carol R Horowitz, et al.
Pharmacogenomics|February 21, 2019
Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trialCathy R Fulton, Yong Zang, Zeruesenay Desta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 31, 2018
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 13, 2018
Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
Pageof 2